On the encapsulation of OLSALAZINE (cas 15722-48-2) by β-cyclodextrin: A DFT-based computational and spectroscopic investigations
-
Add time:09/05/2019 Source:sciencedirect.com
In this work, the supramolecular host-guest interaction of the prodrug OLSALAZINE (cas 15722-48-2) (OLZ) and β-Cyclodextrin (β-CD) was examined experimentally and computationally. Experimentally, employing the UV–Vis spectroscopic method in aqueous media at various pH's, results obtained using the Benesi-Hilderbrand approach demonstrated that OLZ can form supramolecular inclusion complex with β-CD with stoichiometric ratio of 1:1. Furthermore, these results revealed that the formation of OLZ: β-CD complexes exhibited insignificant pH dependency in the range 5–8 with an average binding constant (Kb) of approximately 1 × 103 M−1. Computationally, geometry optimization of 1:1 OLZ: β-CD complexes was performed employing the ONIOM (DFT((ωB97XB)/6–31 + G(d)),SQM(PM3)) approach. Obtained results demonstrated that OLZ: β-CD complex is stabilized by the formation of intermolecular hydrogen bonds with an average length of approximately 1.8 Å. Additionally, the stability of OLZ: β-CD complex was demonstrated employing ADMP molecular dynamic simulations over a timeframe of 500 fs. The molecularity of the supramolecular host-guest interaction between OLZ and β-CD is presented and interpreted in the essence of TD-DFT and molecular orbitals analyses.
We also recommend Trading Suppliers and Manufacturers of OLSALAZINE (cas 15722-48-2). Pls Click Website Link as below: cas 15722-48-2 suppliers
Prev:Synthesis of novel (bio) degradable linear azo polymers conjugated with OLSALAZINE (cas 15722-48-2)
Next:Research paperEx vivo evaluation of degradation rates of metronidazole and OLSALAZINE (cas 15722-48-2) in distal ileum and in cecum: The impact of prandial state) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Determination of mesalazine, a low bioavailability OLSALAZINE (cas 15722-48-2) metabolite in human plasma by UHPLC–MS/MS: Application to a pharmacokinetic study09/24/2019
- An experimental study on ulcerative colitis as a potential target for probiotic therapy by Lactobacillus acidophilus with or without “OLSALAZINE (cas 15722-48-2)”09/10/2019
- Two three-dimensional pillared metal–OLSALAZINE (cas 15722-48-2) complexes based on infinite rod-shaped secondary building units09/09/2019
- Degradation kinetics of metronidazole and OLSALAZINE (cas 15722-48-2) by bacteria in ascending colon and in feces of healthy adults09/08/2019
- Full paperOld drug, new indication: OLSALAZINE (cas 15722-48-2) sodium reduced serum uric acid levels in mice via inhibiting xanthine oxidoreductase activity09/07/2019
- Research paperEx vivo evaluation of degradation rates of metronidazole and OLSALAZINE (cas 15722-48-2) in distal ileum and in cecum: The impact of prandial state09/06/2019
- Synthesis of novel (bio) degradable linear azo polymers conjugated with OLSALAZINE (cas 15722-48-2)09/04/2019
- Enzyme and PH responsive 5-flurouracil (5-FU) loaded hydrogels based on OLSALAZINE (cas 15722-48-2) derivatives for colon-specific drug delivery09/03/2019


